Introduction. In 2020, breast cancer was the most frequently diagnosed malignancy worldwide. The QoL level plays a role in assessing the effectiveness of the diagnosis and therapy and is a significant prognostic factor. The subject that is relatively less often addressed in the literature is the impact of psycho-social factors and health-related beliefs on QoL in breast cancer patients. The aim of the study was to assess the association of illness perception, the sense of coherence, and illness acceptance with QoL in breast cancer patients. Methods. The study included 202 women (mean age 53.0 ± 10.3) treated surgically for breast cancer at the Lower Silesian Oncology Centre. The following standardized questionnaires were used: Acceptance of Illness Scale (AIS), Mental Adjustment to Cancer (Mini-MAC), Quality of Life Questionnaires (EORTC QLQ-C30 and QLQ-BR23), The Multidimensional Essence of Disease and Illness Scale (MEDIS), and Life Orientation Test (LOT-R). Results. There is a statistically significant association between illness acceptance and QoL. There is a statistically significant association between the sense of coherence (life optimism—LOT-R) and QoL among breast cancer patients. There is a statistically significant association between illness perception and QoL. There was a statistically significant correlation between the increasing importance of illness as a dysfunction, decreasing QoL, and increasing intensity of symptoms and complaints. Conclusions. Patients with a high level of illness acceptance, with an optimistic disposition, and with a positive illness perception have better QoL within all the functional domains and experience lower intensity of cancer- and treatment-related symptoms as compared to those with low level of illness acceptance, with moderate optimism or a pessimistic disposition, and with neutral or negative illness perception.
Introduction. Head and neck cancer (HNC) is a global epidemiological and clinical problem. In 2020, it was the seventh most common type of cancer worldwide. In 2019, HNC was the fourth most common cause of cancer death among men in Poland. Radiotherapy plays an important role in the treatment of patients with HNC at all clinical stages. However, it is associated with a significant rate of early and late adverse effects. As head and neck cancers are located close to vital anatomical structures, both the local progression of the disease and the treatments used can cause serious problems for patients with HNC, reducing their health-related quality of life (HRQoL) as well as increasing the risk of depressive disorders. Despite this, the current literature lacks research on these aspects of the therapeutic process in the Polish population. The aim of this study was to assess the early impact of radiotherapy on HRQoL outcomes, psychological distress, nutritional status, and overall performance of patients with HNC. Methods. The study was carried out among 85 patients with HNC treated in the Inpatient Radiotherapy Unit of the Radiotherapy Department of the Lower Silesian Oncology Center in Wrocław. The patients were asked to complete a set of questionnaires, including the EORTC QLQ-H&N35, the BDI, the NRS-2002, and the ECOG scale, at two time points: before the initiation of radiotherapy treatment and after a course of radiotherapy. The period between the assessments was 7 to 8 weeks. Results. Our findings demonstrated a negative impact of radiotherapy on scores in all the cancer-specific symptom and functioning scales used in the study. As regards functioning scales, the largest differences were observed for senses and swallowing, whereas with symptoms scales, the largest differences were noted for “sticky saliva” and “dry mouth”. Over half of the patients included in the study required nutritional support after radiotherapy treatment. We found statistically significant differences in the levels of depressive symptom severity before and after radiotherapy treatment. Conclusion. The present study showed significant changes in the physical and psychological functioning and nutritional status of the patients with HNC studied after radiotherapy treatment, which may have an impact on the effectiveness of cancer treatment.
26 February 2026 in Advances in Clinical and Experimental Medicine
Glaucoma is a chronic, progressive optic neuropathy that can lead to irreversible blindness if left untreated. It is the leading cause of irreversible blindness globally. Effective management relies heavily on the control of intraocular pressure (IOP), typically through lifelong pharmacological treatment, but adherence to therapy is often a challenge due to the asymptomatic nature of the disease. The primary aim of this study was to evaluate the predictive influence of the doctor-patient relationship, the quality of communication between doctor and patient, patient knowledge about glaucoma, and quality of life when adhering to therapeutic recommendations among a group of Polish glaucoma patients. This study was conducted at the Ophthalmology Outpatient Clinic of the University Clinical Hospital in Wrocław, Poland. A total of 190 patients were enrolled, and adherence to treatment was assessed using the Adherence to Refills and Medications Scale (ARMS). Additional variables included patient-physician communication (CAT-14), relationship quality (PDRQ-9), visual function (NEI VFQ-25), and glaucoma knowledge (GKQ-10). The results indicated that 58.9% of patients showed low adherence to their prescribed treatment. Satisfaction with doctor-patient communication, higher levels of knowledge about glaucoma, and better visual function were significantly associated with better adherence. The quality of the patient-physician relationship, while not statistically significant, also showed potential positive effects on adherence. Improving patient education and enhancing the quality of communication between healthcare providers and patients are critical to increasing adherence to glaucoma treatment. Importantly, the study provides a valuable evidence base for developing adherence-enhancing strategies within the Polish healthcare system. Given the scarcity of such data in Central and Eastern Europe, our results may also inform similar efforts in the region. Designing culturally sensitive and system-specific interventions, such as brief communication training for ophthalmologists or structured patient education programs, could help address persistent adherence challenges in chronic ophthalmic care.